International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 4 : 3612-3617
Research Article
 ,
 ,
 ,
 ,
Received
June 12, 2026
Accepted
July 15, 2026
Published
July 31, 2026
Abstract

Background: Septicemia is a leading cause of morbidity and mortality with complex pathogenesis depending on Virulence and pathogen load, as well as host factors. In addition to antimicrobial therapy it is essential to identify any possible source of sepsis as failure of source control is an important reason for treatment failure and disease progression.

Objectives:

  1. To Isolate Bacterial pathogens from Blood cultures.
  2. To Determine Antimicrobial Susceptibility pattern of Blood culture positive isolates.
  3. To Generate Syndromic Antibiogram to support evidence based empirical therapy for Sepsis.

Methods: A Prospective Cross-sectional study was done over a period of 1 year with Predefined Inclusion, Exclusion criteria and sample size of 380. Blood samples collected under strict aseptic precautions processed by automated BACTEC system as per manufacturer’s protocols. Antibiotic susceptibility testing was done on Mueller Hinton agar using Modified Kirby Bauer Disc Diffusion method. Statistical data analyzed using SPSS software, Chi-square test and odds ratio with 95% Confidence intervals.

Results: Out of the 380 samples, 107 (28%) were positive for Bacterial growth, while 184 (48%) samples showed no growth and 89 (23%) showed mixed growth. Gram positive isolates were (63.5%) predominant over Gram negative isolates (36.4%) and Neonates, Pediatric group predominance over adult group. CONS, S.aureus, Klebsiella pneumonia followed by Pseudomonas, E.coli are predominant isolates.

Conclusion: Early Diagnosis and commencement of antimicrobial therapy and appropriate empirical treatment play a vital role in reducing mortality and morbidity. Blood culture, a Gold standard technique in Diagnosis of Sepsis.

Keywords
INTRODUCTION

Septicemia is defined as a condition in which bacteria circulate and actively multiply in the bloodstream and produce their products like toxins that cause harm to the host, that may or may not be associated with Bloodstream Infections (BSI).Septicemia is a leading cause of morbidity and mortality among developing and developed nations with complex pathogenesis depending on Virulence and pathogen load, as well as host factors and neonates particularly vulnerable to septicemia because of their weak immune system 1, 2. Septicemia may be mono or polymicrobial in nature and present with nonspecific signs and symptoms like severe febrile episodes of fever, chills, malaise, tachycardia, mental confusion, hyperventilation, hypotension or shock. Infections causing sepsis could be community acquired or hospital acquired, Pneumonia accounts for 50% of causes of sepsis followed by intraabdominal and genitourinary infections. In Hospital settings gram negative infections predominant with most common organisms being Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa 1. Aim of the study includes To Diagnose and Treat Sepsis ,a medical emergency in order to minimize severity and degree of organ failure as patients with septic shock have a mortality of >40% in contrast to 10% for sepsis cases. In addition to antimicrobial therapy it is essential to identify any possible source of sepsis such as removal of central line, abscess drainage etc. as failure of source control is an important reason for treatment failure and disease progression.

 

OBJECTIVES

  1. To Isolate Bacterial pathogens from Blood cultures.
  2. To Determine Antimicrobial Susceptibility pattern of Blood culture positive isolates.
  3. To Generate Syndromic Antibiogram to support evidence based empirical therapy for Sepsis.

 

MATERIALS & METHODS

  • Study Design and Settings :

This Prospective Cross-sectional study was done over a period of 1 year from July 2025 to June 2026 in the Department of Microbiology, Navodaya Medical College, and Raichur.

 

  • Sample Size :

Sample size of this study is calculated with reference to article 5 by using formulae n = Z2p q/d2

Z=1.96 (95% Confidence level), p=42%=0.42, q=1-p=0.58.

n=3.8416×0.2436/0.0025=374.37. So sample size of this study 380.

 

  • Inclusion Criteria:
  1. Subjects with symptoms and signs of septicemia like fever, chills, malaise, tachycardia, hyperventilation, toxicity.
  2. All Gram positive and Gram negative bacteria isolated from blood samples.

 

  • Exclusion Criteria:
  1. Subjects without symptoms and signs of septicemia
  2. All no growth and contaminated Clinical samples are excluded.
  3. All mixed samples will be excluded.

 

METHODOLOGY:

  • Sample collection and Processing :

Blood samples collected according to standard operational procedures under strict aseptic precautions by proper skin decontamination, 2 sets of adults and pediatric BACTEC bottles per patient and processed by automated BACTEC system as per manufacturer’s protocols.

 

  • Blood culture by automated blood culture system: For the automated blood culture system, 8-10ml each of blood for adults and 1-3ml of blood for pediatric age will be inoculated into Aerobic and Anaerobic BACTEC PLUS bottles and will be loaded into the machine. As soon as an audible or visible alert given by the BACTEC FX40, it will be treated as a positive blood culture and sub cultures will be done into appropriate liquid media. Preliminary tests like Gram’s stain, hanging drop, catalase, and oxidase test will be done and appropriate biochemical reactions like Slide Coagulase, Tube Coagulase, Bile Aesculin Agar, Optochin Sensitivity, and Bacitracin Sensitivity will be put for Gram Positive Cocci and Indole Test, Citrate and Urease Reaction, Triple Sugar Iron Agar for Gram Negative Bacilli. If there was no alert, audible or visible, the bottles will be incubated for 7 days before undergoing a terminal subculture, to report as negative.

 

  • Antibiotic susceptibility testing: Antibiotic susceptibility testing will be carried out on Mueller Hinton agar using modified Kirby Bauer Disc Diffusion method by using the Hi Media Antibiotic Discs and Syndromic cumulative antibiogram will be generated. 1, 3, 4.

 

  • Statistical analysis:

Data were analyzed using SPSS software. Chi-square test was applied and odds ratio with 95% Confidence intervals were calculated. A p value of < 0.05 was considered statistically significant.

 

  • Ethical clearance: Approval was obtained from the ethical committee of the institute for this study               

 

RESULT

During the study period from July 2025 to January 2026, a total of 380 samples with clinical suspicion of septicemia were investigated. Blood samples were collected under strict aseptic precautions and processed for culture. Out of the 380 samples analyzed, 107 (28%) were positive for bacterial growth, while 184 (48%) samples showed no growth and 89 (23%) showed mixed growth and among Culture positive distribution, Gram positive isolates were (63.5%) predominant over Gram negative isolates (36.4%) and age wise Distribution of isolates shows Neonates , Pediatric group predominance over adult group as shown in Tables 1-5 and Figure 1-5.Antimicrobial Susceptibility testing of Gram positive and Gram negative isolates shown in Table 6-7.

 

Table 1- sample distribution

Culture

Number

Percentage (%)

Culture Positive

107

28 %

Culture Negative

184

48 %

Mixed culture

89

23 %

Total

380

100 %

 

Table 2: Age-wise distribution of culture positive cases

Gender

Number

Percentage (%)

Adult

24

22 %

Pediatrics including Neonates

83

78 %

Total

107

100 %

 

Figure 1: Distribution of Isolates

 

Figure 2: Age wise distribution

 

Table 3: Distribution of Isolates

Isolate

Number of isolates

Percentage (%)

Gram positive isolates

68

63.5%

Gram Negative isolates

39

36.4%

Total

107

100 %

 

Figure 3: Percentage %

 

Table 4: Distribution of Gram positive isolates

S.no

Gram Positive Isolate

No of Isolates

Percentage (%)

1.

CONS

33

49 %

2.

S.aureus

32

47 %

3.

Enterococcus

03

04%

 

Total

68

100 %

 

Figure 4 : Distribution of Gram positive isolates (n= 68)

 

Table 5: Distribution of Gram negative isolates

S.no

Gram Negative Isolate

No of Isolates

Percentage (%)

1

Klebsiella

21

54%

2

Pseudomonas

9

23.07%

3

E.coli

3

7.7%

4

Acinetobacter

2

5.12%

5

Citrobacter

2

5.12%

6

Proteus

1

2.5%

7

Non fermenter

1

2.5%

 

Total

39

100%

 

Figure 5: Distribution of Gram Negative isolates (n= 39)

 

Table 6: Antimicrobial Susceptibility Testing of Gram negative isolates (n= 39)

Isolate (39)

AK

CIP

COT

DOX

AMC

CFS

PTZ

MRP

CTX

Klebsiella lla (21)

6

(28.6%

)

8

(38%)

14

(66.6%

)

8

(38.09

%)

19

(90.5%

)

10

(48%)

11

(52.3%)

10

(48%)

12

(57.1%)

Pseudo monas (9)

3

(33.3%

)

6

(66.7%

)

1

(11%)

1

(11%)

1

(11%)

5

(55.5%)

4

(44.4%)

5

(55.5%)

4

(44.4%)

E.coli

(3)

1

(33.3%

)

1

(33.3%

)

2

(66.6%)

2

(66.6%)

3

(100%)

1

(33.3%)

1

(33.3%)

1

(33.3%)

2

(66.6%)

Acinet obacter (2)

1

(50%)

1

(50%)

1

(50%)

1

(50%)

1

(50%)

0

1

(50%)

1

(50%)

0

Citroba

cter (2)

1

(50%)

0

1

(50%)

1

(50%)

0

1

(50%)

0

1

(50%)

0

Proteus (1)

1

(100%)

1

(100%)

0

0

1

(100%)

1

(100%)

0

0

1

(100%)

Non fermenter (1)

1

(100%)

11

(100%)

0

1

(100%)

1

(100%)

1

(100%)

1

(100%)

0

0

 

Table 7: Antimicrobial Susceptibility Testing of Gram positive isolates (n= 68)

Isolate (68)

AMP

A ZM

CIP

COT

DOX

E

CD

G

LE

CX

VA

LZ

CONS (33)

16

(48.5

%)

6

(18.2

%)

20

(60.6

%)

16

(48.5%)

1

(3%)

1

(3%)

3

(9%

)

3

(9%)

17

(51.

5%)

19

(57.6

%)

2

(6%)

1

(3%)

S.aureus (32)

18

(15.6

%)

5

(15.6

%)

12

(36.3

%)

18

(15.6%)

2

(6%)

1

(3%)

1

(3%

)

1

(3%)

16

(50

%)

17

(53.1

%)

1

(3%)

1

(3%)

Entero coccus (3)

3

(100

%)

1

(33.3

%)

1

(33.3

%)

3

(100%)

0

0

0

0

2(66

.7%)

1

(33.3

%)

0

0

 

DISCUSSION

  • Bloodstream infections (BSI) are major contributors of sepsis and rapid identification of the causative organism and antimicrobial treatment can reduce morbidity and mortality. This study attempted to analyze bacterial profiles and assess their antimicrobial susceptibility trends to formulate an antibiogram and effective empirical treatment of bloodstream infections.
  • In the Present study, Blood culture positivity rate is 28% that aligns with study of Akshatha Peddinti, et al which has 27, 27% and is lower than the study Of Arun T L et al which has 42.4% of culture confirmed BSI and of Datta, et al. which has 32%. Such variability across studies may be influenced by several factors, including prior empirical antibiotic therapy, undetected viral or fungal infections, differences in patient demographics, and variability in laboratory practices and infection control measures among institutions 6.
  • In the present study, study population included patients across all age groups and positive culture shows predominance of neonates and pediatric patients about 78%. Adults and elderly individuals constituted a comparatively smaller proportion of cases of about 22% that correlates with studies by Arun T L et al, which highlights neonate’s predominance, particularly vulnerable to septicemia and in contrast to study by Datta et al, highest incidence of positive cultures (37%) was observed in patients aged 60–75 yrs.
  • In Present study Distribution of isolates, Gram positive isolates (63.5%) shows predominance over Gram negative isolates (36.4%). In Gram positive distribution of isolates, CONS followed by S.aureus that aligns with studies by Wajid & Naaz , Kaur C, Sharma S et.al that shows predominance of Gram positive over Gram negative and in Gram negative distribution of isolates , Klebsiella pneumonia followed by Pseudomonas, E.coli and other isolates correlates to study done by Akshatha Peddinti, et al, Arun T L et al which shows predominance of Klebsiella , Pseudomonas , Acinetobacter spp .
  • Antimicrobial susceptiblity profile of Gram positive isolates shows highest sensitivity for Cefoxitin (CX),Ciprofloxacin (CIP), Levofloxacin (LE),Ampicillin (AMP), cotrimaxozole (COT) and highest resistance shown to Erthromycin (E),Clindamycin (CD),Gentamicin (G). Overall Methicillin sensitive Staphylococcus aureus and CONS are more than Methicillin Resistant comparable to findings from Wajid & Naaz .
  • Antimicrobial susceptiblity profile of Gram negative isolates shows highest sensitivity to amoxicillin-clavulinate (AMC), piperacillin-Tazobactum (PIT) ,Cotrimaxozole (COT), Cefperazone-sulbactum (CFS), 3rd Generation Cephalosporin (CTX), Meropenem (MRP) and highest resistance to amikacin (AK),ciprofloxacin(CIP) comparable to findings from Akshatha Peddinti, et al, Arun T L et al.

 

CONCLUSION

Early Diagnosis and commencement of antimicrobial therapy can play a vital role in reducing mortality and morbidity and appropriate empirical treatment is based on continuous knowledge of causative agents and their resistance patterns. Our study has provided information about likely pathogens in bloodstream Infections and their resistance patterns in the rural setup and Importance of Blood culture as a Gold standard in Diagnosis which help in Diagnosis, formulating Antibiotic policy and avoid indiscriminate antibiotic use.

 

REFERENCES

  1. Essentials of Antimicrobial stewardship by Apurba S Sastry, 1st edition. Empirical antimicrobial agents for sepsis and BSI Jaypee Brothers Medical Publishers (P) Ltd.
  2. Apurba S Sastry Essentials of Medical Microbiology, (4th Edition). Sepsis and BSI. Jaypee Brothers Medical Publishers (P) Ltd
  3. Konemans color atlas and textbook of Diagnostic Microbiology (7th edition) by Gary W.
  4. Bailey and Scotts Diagnostic Microbiology, (15th edition) by Patricia M.tille, Elsevier publications.
  5. Dr Arun T L et al. Microbiological Profile and Antimicrobial Resistance Patterns of Bloodstream Infections in a Tertiary CareHospital in South India: A Cross-Sectional Study. Int. J Med.Pharm. Res., 7(3): 2579‐2584, 2026
  6. Akshatha Peddinti, et al. Bacteriological Profile and Antimicrobial Susceptibility Patterns of Blood Culture Isolates in Neonatal Septicemia at a Tertiary Care Hospital in Kurnool, Andhra Pradesh. Int. J Med. Pharm. Res., 7(1): 1713‐ 1719, 2026
  7. Datta, Sangeeta; Kumar, Avinash*; Chatterjee, Biswaroop. Microbiological profile and antimicrobial resistance patterns of bloodstream infections in a tertiary care hospital in eastern India. Current Medicine Research and Practice 15(4): p 145-150, Jul–Aug 2025.
  8. Kaur C, Sharma S. Bacteriological Profile and their Antibiotic Susceptibility Pattern in Bloodstream Infections in a Tertiary Care Hospital in North India. J Pure Appl Microbiol. 2022; 16(4):2756-2763. doi: 10.22207/JPAM.16.4.46.
  9. Wajid M, Naaz S. A study of bacteriological profile and antimicrobial susceptibility pattern of bacteria isolated from blood stream infections in a tertiary care hospital [Internet]. Panacea J Med Sci. 2023 [cited 2026 Feb 16]; 13(1):175-180.
  10. Padmaja N, .V S, Sree K. Bacterial isolates & their resistance patterns from blood cultures,KIMS [Internet]. IP Int J Med Microbiol Trop Dis. 2022 [cited 2026 Feb 16]; 8(2):154-158.
Recommended Articles
Research Article Open Access
Bacteriological Profile and Antimicrobial Susceptibility pattern of Blood culture positive isolates from Septicemia patients in a tertiary care Centre
2026, Volume-7, Issue 4 : 3617-3622
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 4
Citations
1 Views
2 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved